Mosaic 13q14 deletions in peripheral leukocytes of non-hematologic cancer cases and healthy controls.
Machiela MJ, Zhou W, Caporaso N, Dean M, Gapstur SM, Goldin L, Stevens VL, Yeager M, Chanock SJ
Loss of 13q14.3 is a chromosomal event found in ~50% of B-cell chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL) cases. Surveys of somatic alterations in solid tumors have shown sporadic 13q14.3 loss in many different tumor types, but not at high frequency in any specific tumor type. In our recent survey of the single-nucleotide polymorphism (SNP) microarray data from 127 000 cancer-free or solid tumor cases, we observed mosaic 13q14.3 loss as common autosomal somatic large structural events (>2 Mb in size) in blood and buccal-derived DNA. Herein, we examined this region more closely investigating structural mosaic events <2 Mb using SNP microarray data in 46 254 non-hematologic cancer cases and 36 229 controls. We detected 60 individuals with 13q14.3 mosaic loss, 1 mosaic copy neutral uniparental disomy and 13 individuals with homozygosity. Although 13q14.3 loss size was variable, the minimally deleted region (MDR) (chr13: 49 590 000-49 983 100; GRCh36) was comparable to what is classically reported in MBL and CLL. Breakpoint analysis of the estimated boundaries reveals enrichment for genes and open chromatin. The frequency of 13q14.3 loss significantly increases with increasing age (P-value=0.028), but was not significantly different between non-hematological cancer cases and controls (0.084% versus 0.058%; P-value=0.19). These findings suggest that mosaic 13q14.3 losses accumulate with age. Individuals with detected mosaic 13q14.3 deletions may be early, undetected cases of MBL or CLL, but not necessarily all will develop MBL and CLL.
- 2010-0145: A prospective study of immunologic markers and risk of lymphoid malignancies (Mark Purdue - 2011)
- 2009-0558: Markers of susceptibility to ovarian cancer risk and survival in PLCO (Nicolas Wentzensen MD - 2010)
- 2010-0050: Genetic susceptibility to endometrial cancer risk in PLCO (Nicolas Wentzensen MD - 2010)
- 2007-0253: Genome-wide association study of renal cell carcinoma: replication scan (Mark Purdue - 2008)
- 2007-0224: Whole Genome Association Study (GWAS) of Bladder Cancer (Stella Koutros - 2007)
- 2007-0004: A Whole Genome Association Study (WGAS) of Lung Cancer and Smoking (Neil Caporaso - 2007)
- 2006-0306: Whole Genome Scan of Incident Pancreatic Cancer in the Cohort Consortium (PanScan) (Rachael Stolzenberg-Solomon - 2006)
- 2006-0301: Cancer Genetic Markers of Susceptibility (CGEMS): Contribution of Breast Cancer Cases and Controls from PLCO Cancer Screening Trial (Montserrat Garcia-Closas - 2006)
- 2005-0003: C-GEMS: Cancer Genetic Markers of Susceptibility A Strategic Initiative to Identify Novel Genetic Determinants of Cancer (Mitchell Machiela - 2005)